Unitedhealth Group Inc (UNH) Stock Forecast & Predictions

Unitedhealth Group Inc UNH: $408.03

9900 Bren Rd E, Hopkins, Minnesota, US. | Sector: Finance and Insurance | Exchange: NEW YORK STOCK EXCHANGE INC. | Web: www.unitedhealthgroup.com

  • Market Cap$384.74B
  • Change (52 Weeks)41.43%
  • Low (52 Weeks)$287.09
  • Unitedhealth Group Inc (UNH) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 25.00% are on Buy, 25.00% on Sell, and 50.00% Neutral.

    According to the market data, Unitedhealth Group Inc (UNH) stock price is $408.03 and the 52 weeks low is $287.09, which means the Unitedhealth Group Inc stock price is up 41.43% in the last 12 months.

    Unitedhealth Group Inc (UNH) Stock Price has been Trending Strongly with an ADX reading of 27.95 as per the Weekly Chart.

    A Upward trend indicates that Unitedhealth Group Inc (UNH) Stock Price may keep going up, with temporary Retracement (the process of stock price bouncing because of short term profit taking by the traders and investors).

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 25.00% are indicating that UNH Stock price might rise further, 25.00% indicating that UNH Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall UNH stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Unitedhealth Group Inc (UNH) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Unitedhealth Group Inc (UNH) is based on 33 Institutional Analyst Ratings where 51.52% are on Strong Buy, 33.33% on Moderate Buy, 15.15% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 33 Institutional Analysts, majority recommended UNH stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Unitedhealth Group Inc.

    Unitedhealth Group Inc (UNH) Stock Price Prediction By Analysts


    HighLowAverage
    $548.10$363.60$471.09
    $471.0915.46% Upside
    Updated: 2021-09-19 00:00:00

    The Average Price target for UNH set by the institutional analysts is $471.09 where High Estimate is $548.10, Median $472.77 and Low $363.60.

    The average price target for UNH by Institutional Analysts is $471.09, which is 15.46% Upside from the current price. So according to the Institutional Analysts, UNH Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Unitedhealth Group Inc (UNH) Stock Forecast Based on Investor Sentiment


    Very Negative

    Based on 478,822 investor portfolio.

    Our algorithm has analysed 478,822 investor portfolio with UNH stock holdings and found that 18.00% of them are bullish. Which means the Investor Sentiment is mostly Very Negative.

    This shows most investors think UNH stock is heavily overvalued currently and majority of them have already closed their UNH position and don't intend to buy anymore at this stage.

    Unitedhealth Group Inc (UNH) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Morgan StanleyOverweightMaintained
    Truist SecuritiesBuyMaintained
    Stephens & Co.OverweightMaintained
    Raymond JamesStrong BuyMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    BarclaysOverweightMaintained
    Seaport GlobalBuyInitiated
    Truist SecuritiesBuyMaintained
    Wells FargoOverweightInitiated
    Argus ResearchBuyUpgraded
    Stephens & Co.OverweightMaintained
    OppenheimerOutperformMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    BMO CapitalMarket PerformMaintained
    BarclaysOverweightMaintained
    Truist SecuritiesBuyMaintained
    MizuhoBuyMaintained
    SVB LeerinkOutperformMaintained
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseOutperformMaintained
    UBSNeutralMaintained
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    JefferiesHoldMaintained
    B of A SecuritiesBuyMaintained
    SVB LeerinkOutperformMaintained
    Raymond JamesStrong BuyMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    JefferiesHoldMaintained
    SVB LeerinkOutperformInitiated
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    Stephens & Co.OverweightMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Morgan StanleyOverweightMaintained
    Deutsche BankBuyUpgraded
    Deutsche BankHoldMaintained
    UBSNeutralMaintained
    OppenheimerOutperformMaintained
    CitigroupBuyMaintained
    Cantor FitzgeraldOverweightReiterated
    Stephens & Co.OverweightMaintained
    Credit SuisseOutperformMaintained
    JP MorganOverweightMaintained
    SunTrust Robinson HumphreyBuyMaintained
    Goldman SachsBuyMaintained
    Wells FargoOverweightMaintained
    Raymond JamesStrong BuyReiterated
    Wells FargoOutperformMaintained
    UBSNeutralMaintained
    Credit SuisseOutperformMaintained
    Cantor FitzgeraldOverweightMaintained
    BarclaysOverweightMaintained
    MizuhoBuyReiterated
    Morgan StanleyOverweightMaintained
    SunTrust Robinson HumphreyBuyMaintained
    MizuhoBuyInitiated
    UBSNeutralMaintained
    CitigroupBuyMaintained
    JefferiesHoldDowngraded
    BMO CapitalMarket PerformDowngraded
    Morgan StanleyOverweightMaintained
    Deutsche BankHoldInitiated
    Morgan StanleyOverweightMaintained
    UBSNeutralInitiated
    Raymond JamesStrong BuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupNeutralMaintained
    BarclaysOverweightMaintained
    Stephens & Co.OverweightInitiated
    ArgusBuyMaintained
    Raymond JamesStrong BuyMaintained
    Bank of AmericaBuyMaintained
    BarclaysOverweightMaintained
    JefferiesBuyMaintained
    Raymond JamesStrong BuyMaintained
    Cowen & Co.OutperformInitiated
    CitigroupNeutralDowngraded
    Morgan StanleyOverweightMaintained
    RBC CapitalOutperformMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    BMO CapitalOutperformMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseOutperformMaintained
    BarclaysOverweightInitiated
    Goldman SachsBuyInitiated
    Credit SuisseOutperformInitiated
    ArgusBuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    Bank of AmericaBuyMaintained
    BMO CapitalOutperformInitiated
    JefferiesBuyMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    BarclaysOverweightMaintained
    Bank of AmericaBuyMaintained
    Deutsche BankBuyMaintained
    Morgan StanleyOverweightInitiated
    Deutsche BankBuyInitiated
    Cantor FitzgeraldOverweightInitiated
    PiperJaffrayOverweightInitiated
    Cantor FitzgeraldBuyUpgraded
    OppenheimerOutperformMaintained
    MizuhoBuyUpgraded
    JP MorganOverweightMaintained
    JefferiesBuyMaintained
    Credit SuisseOutperformMaintained
    MizuhoNeutralDowngraded
    Evercore ISI GroupBuyInitiated
    Argus ResearchBuyUpgraded
    ArgusBuyUpgraded
    CitigroupBuyMaintained
    BarclaysOverweightMaintained
    BernsteinOutperformInitiated
    Cleveland ResearchBuyInitiated
    MizuhoBuyMaintained
    Credit SuisseOutperformMaintained
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    Credit SuisseOutperformInitiated
    BMO CapitalOutperformMaintained
    JP MorganOverweightInitiated
    Sterne Agee CRTBuyUpgraded
    RBC CapitalOutperformInitiated
    BarclaysOverweightMaintained
    JefferiesBuyUpgraded
    Leerink SwannOutperformMaintained
    Credit SuisseOutperformMaintained
    MizuhoBuyInitiated
    BarclaysOverweightMaintained
    Deutsche BankBuyMaintained
    Leerink SwannOutperformMaintained
    Deutsche BankBuyMaintained
    BarclaysOverweightMaintained
    BarclaysOverweightMaintained
    Goldman SachsNeutralDowngraded
    Deutsche BankBuyMaintained
    Stifel NicolausBuyMaintained
    OppenheimerOutperformMaintained
    Credit SuisseOutperformMaintained
    Cantor FitzgeraldHoldMaintained
    Bank of AmericaBuyMaintained
    JefferiesHoldMaintained
    CitigroupNeutralMaintained
    BarclaysOverweightMaintained
    PiperJaffrayOverweightInitiated
    Raymond JamesStrong BuyMaintained
    FBR CapitalOutperformMaintained
    Deutsche BankBuyMaintained
    Credit SuisseOutperformMaintained
    BarclaysOverweightMaintained
    Deutsche BankBuyMaintained
    JefferiesHoldDowngraded
    Sterne AgeeUnderperformInitiated
    CitigroupNeutralMaintained
    BMO CapitalOutperformMaintained
    JefferiesBuyMaintained
    Deutsche BankBuyMaintained
    CitigroupHoldDowngraded
    Cantor FitzgeraldHoldMaintained
    Monness Crespi HardtSellDowngraded
    Deutsche BankBuyUpgraded
    UBSBuyMaintained
    Morgan StanleyOverweightInitiated
    JP MorganOverweightMaintained
    Leerink SwannMarket PerformInitiated
    FBR CapitalOutperformInitiated
    Monness Crespi HardtNeutralDowngraded
    Cantor FitzgeraldHoldDowngraded
    Monness Crespi HardtBuyMaintained
    Deutsche BankHoldMaintained
    BMO CapitalOutperformMaintained
    Monness Crespi HardtBuyMaintained
    Deutsche BankHoldMaintained
    JefferiesBuyMaintained
    Standpoint ResearchHoldDowngraded
    Deutsche BankHoldMaintained
    Credit SuisseOutperformMaintained
    UBSBuyInitiated
    Raymond JamesStrong BuyUpgraded
    JefferiesBuyMaintained
    Deutsche BankHoldMaintained
    Standpoint ResearchBuyUpgraded
    OppenheimerOutperformUpgraded
    Deutsche BankHoldDowngraded
    Goldman SachsNeutralMaintained
    Deutsche BankBuyMaintained
    Deutsche BankBuyMaintained
    Bank ofericaBuyMaintained
    WedbushOutperformMaintained
    Bank ofericaBuyMaintained
    Bank ofericaBuyMaintained

    Unitedhealth Group Inc (UNH) Stock Earning Per Share (EPS) Forecast / Estimate


    $4.394
    The average consensus EPS for UNH is $4.394 with a high estimate of $5.009 and Low of $4.057 for the period 2021-12-31 and based on 24 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $4.7$4.47843092021-06-30


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $$4.44510092021-09-30
    $4.7$4.47843092021-06-30
    $5.31$4.4267292021-03-31
    $2.52$2.43674622020-12-31
    $3.51$3.12363712020-09-30
    $7.12$5.32930542020-06-30
    $3.72$3.66208832020-03-31
    $3.9$3.8119422019-12-31
    $3.88$3.78407612019-09-30
    $3.6$3.48709570000000022019-06-30
    $3.73$3.63260642019-03-31
    $3.28$3.24065572018-12-31
    $3.41$3.32547552018-09-30
    $3.14$3.06554192018-06-30
    $3.04$2.92338439999999982018-03-31
    $2.59$2.53990762017-12-31
    $2.66$2.58840782017-09-30
    $2.46$2.40208299999999972017-06-30
    $2.37$2.18962949999999972017-03-31
    $2.11$2.09388152016-12-31
    $2.17$2.10008292016-09-30
    $1.96$1.90592052016-06-30
    $1.75$1.73930082016-03-31
    $1.4$1.3905682015-12-31
    $1.65$1.65159242015-09-30
    $1.64$1.60034500000000012015-06-30
    $1.46$1.36111642015-03-31
    $1.55$1.51339412014-12-31
    $1.63$1.54380520000000022014-09-30
    $1.42$1.26902459999999982014-06-30
    $1.1$1.09814272014-03-31
    $1.41$1.41669670000000012013-12-31
    $1.53$1.54196699999999992013-09-30
    $1.4$1.26525729999999982013-06-30
    $1.16$1.1527132013-03-31
    $1.2$1.20670762012-12-31
    $1.5$1.36409592012-09-30
    $1.27$1.20236460000000012012-06-30
    $1.31$1.17981132012-03-31
    $1.17$1.04559239999999992011-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).